CN107459500A
|
|
A kind of pipeline synthesis technique for arranging net class medicine
|
CN105395494A
|
|
Medicine composition containing succinic acid solifenacin and preparation method of medicine composition
|
CN105168172A
|
|
Erlotinib hydrochloride tablet with improved dissolution rate and stability and preparation method thereof
|
CN105061393A
|
|
Synthetic method for (S)-(-)-3-methylamino-1-(2-thienyl)-1-propanol
|
CN105061224A
|
|
Synthetic method of L-2-aminobutanol
|
CN104529935A
|
|
Method for synthesizing high-purity ethyl 2-(3-aldehyde-4-isobutyloxyphenyl)-4-methylthiazole-5-formate
|
CN104434872A
|
|
Stable duloxetine hydrochloride enteric capsule and preparation method thereof
|
CN103494796A
|
|
Stable pharmaceutical composition of pregabalin and preparation method thereof
|
CN102020637A
|
|
Preparation method of 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole
|
CN102093280A
|
|
Preparation method of levetiracetam
|
CN101875678A
|
|
Method for preparing clarithromycin
|
CN101417910A
|
|
Green nitration method of prazoles intermediate
|
CN101318928A
|
|
Process for the separation of 2-hydroxymethyl-3, 5-dimethyl-4-methoxy pyridine
|